Syncona Limited
Overview
Syncona Limited is a FTSE250 healthcare investment trust focused on founding, building, and funding a portfolio of global leaders in life science to deliver transformational treatments to patients.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Purespring Therapeutics | Oct 2024 | Series B | Co-investor |
| Beacon Therapeutics | Jul 2024 | Series B | Co-investor |
| iOnctura | Jun 2024 | Series B | Lead |
| SwanBio Therapeutics | Jun 2024 | M&A | Co-investor |
| SwanBio Therapeutics | May 2022 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
